GURUFOCUS.COM » STOCK LIST » Consumer Defensive » Consumer Packaged Goods » NeoPharm Co Ltd (XKRX:092730) » Definitions » Cyclically Adjusted FCF per Share

NeoPharm Co (XKRX:092730) Cyclically Adjusted FCF per Share : ₩983.66 (As of Mar. 2025)


View and export this data going back to 2007. Start your Free Trial

What is NeoPharm Co Cyclically Adjusted FCF per Share?

E10 is a concept invented by Prof. Robert Shiller, who uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings of a company over the past 10 years. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted FCF per Share and the Cyclically Adjusted Price-to-FCF. The Cyclically Adjusted FCF per Share is the average of the inflation adjusted Free Cash Flow per Share of a company over the past 10 years.

NeoPharm Co's adjusted free cash flow per share for the three months ended in Mar. 2025 was ₩523.131. Add all the adjusted free cash flow per share for the past 10 years together and divide the count will get our Cyclically Adjusted FCF per Share, which is ₩983.66 for the trailing ten years ended in Mar. 2025.

During the past 12 months, NeoPharm Co's average Cyclically Adjusted FCF Growth Rate was 12.60% per year. During the past 3 years, the average Cyclically Adjusted FCF Growth Rate was 10.00% per year. During the past 5 years, the average Cyclically Adjusted FCF Growth Rate was 15.70% per year. Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the Cyclically Adjusted FCF Growth Rate using Cyclically Adjusted FCF per Share data.

During the past 13 years, the highest 3-Year average Cyclically Adjusted FCF Growth Rate of NeoPharm Co was 43.20% per year. The lowest was 10.00% per year. And the median was 25.95% per year.

As of today (2025-06-02), NeoPharm Co's current stock price is ₩14270.00. NeoPharm Co's Cyclically Adjusted FCF per Share for the quarter that ended in Mar. 2025 was ₩983.66. NeoPharm Co's Cyclically Adjusted Price-to-FCF of today is 14.51.

During the past 13 years, the highest Cyclically Adjusted Price-to-FCF of NeoPharm Co was 122.45. The lowest was 9.90. And the median was 27.35.


NeoPharm Co Cyclically Adjusted FCF per Share Historical Data

The historical data trend for NeoPharm Co's Cyclically Adjusted FCF per Share can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

NeoPharm Co Cyclically Adjusted FCF per Share Chart

NeoPharm Co Annual Data
Trend Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24
Cyclically Adjusted FCF per Share
Get a 7-Day Free Trial Premium Member Only Premium Member Only 570.30 704.17 848.94 877.95 936.71

NeoPharm Co Quarterly Data
Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25
Cyclically Adjusted FCF per Share Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 873.50 882.27 895.36 936.71 983.66

Competitive Comparison of NeoPharm Co's Cyclically Adjusted FCF per Share

For the Household & Personal Products subindustry, NeoPharm Co's Cyclically Adjusted Price-to-FCF, along with its competitors' market caps and Cyclically Adjusted Price-to-FCF data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


NeoPharm Co's Cyclically Adjusted Price-to-FCF Distribution in the Consumer Packaged Goods Industry

For the Consumer Packaged Goods industry and Consumer Defensive sector, NeoPharm Co's Cyclically Adjusted Price-to-FCF distribution charts can be found below:

* The bar in red indicates where NeoPharm Co's Cyclically Adjusted Price-to-FCF falls into.


;
;

NeoPharm Co Cyclically Adjusted FCF per Share Calculation

E10 is a concept invented by Prof. Robert Shiller, who uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings of a company over the past 10 years. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted FCF per Share and the Cyclically Adjusted Price-to-FCF. The Cyclically Adjusted FCF per Share is the average of the inflation adjusted Free Cash Flow per Share of a company over the past 10 years.

What is Cyclically Adjusted FCF per Share? How do we calculate Cyclically Adjusted FCF per Share?

Cyclically Adjusted FCF per Share is the average of the inflation adjusted Free Cash Flow per Share of a company over the past 10 years. Let's use an example to explain.

If we want to calculate the Cyclically Adjusted FCF per Share of Wal-Mart (WMT) for Dec. 31, 2010, we need to have the inflation data and the free cash flow per share from 2001 through 2010.

We adjusted the 2001 free cash flow per share data with the total inflation from 2001 through 2010 to the equivalent free cash flow in 2010. If the total inflation from 2001 to 2010 is 40%, and Wal-Mart's free cash flow is $1 a share in 2001, then the 2001's equivalent free cash flow in 2010 is $1.4 a share. If Wal-Mart's free cash flow is $1 again in 2002, and the total inflation from 2002 through 2010 is 35%, then the equivalent 2002 free cash flow in 2010 is $1.35. So on and so forth, you get the equivalent free cash flow per share of past 10 years. Then you add them together and divided the sum by the count to get Cyclically Adjusted FCF per Share.

Please note that we use the CPI data of the country/region where the company is headquartered. If the CPI data for that country/region is not available, then we will use the CPI data of the United States as default.

For example, NeoPharm Co's adjusted Free Cash Flow per Share data for the three months ended in Mar. 2025 was:

Adj_FreeCashFlowPerShare= Free Cash Flow per Share /CPI of Mar. 2025 (Change)*Current CPI (Mar. 2025)
=523.131/122.5900*122.5900
=523.131

Current CPI (Mar. 2025) = 122.5900.

NeoPharm Co Quarterly Data

Free Cash Flow per Share CPI Adj_FreeCashFlowPerShare
201506 41.706 100.051 51.101
201509 14.386 100.111 17.616
201512 184.201 100.220 225.315
201603 -28.114 100.561 -34.273
201606 176.824 100.791 215.068
201609 173.666 101.461 209.831
201612 222.592 101.561 268.681
201703 25.749 102.851 30.691
201706 235.302 102.611 281.116
201709 195.062 103.491 231.061
201712 210.306 102.991 250.327
201803 163.965 104.101 193.087
201806 282.160 104.130 332.180
201809 130.905 105.651 151.894
201812 408.574 104.351 479.988
201903 -110.638 104.491 -129.802
201906 514.417 104.881 601.276
201909 229.979 105.200 267.995
201912 507.787 105.121 592.169
202003 210.803 105.354 245.290
202006 156.422 105.112 182.432
202009 184.018 106.198 212.423
202012 485.336 105.765 562.541
202103 366.698 107.357 418.728
202106 308.621 107.579 351.686
202109 130.388 108.759 146.969
202112 546.228 109.676 610.542
202203 215.107 111.848 235.766
202206 246.664 114.072 265.082
202209 102.519 114.715 109.556
202212 544.746 115.179 579.796
202303 318.153 116.507 334.763
202306 325.399 117.182 340.416
202309 279.668 118.964 288.193
202312 -767.384 118.837 -791.618
202403 23.396 120.123 23.876
202406 189.153 120.007 193.224
202409 123.279 120.861 125.042
202412 635.809 121.135 643.445
202503 523.131 122.590 523.131

Add all the adjusted free cash flow per share together and divide 10 will get our Cyclically Adjusted FCF per Share.


NeoPharm Co  (XKRX:092730) Cyclically Adjusted FCF per Share Explanation

If a company grows much fast than inflation, Cyclically Adjusted FCF per Share may underestimate the company's free cash flow. Cyclically Adjusted Price-to-FCF can seem to be too high even the actual Price-to-Free-Cash-Flow is low.

For the Cyclically Adjusted Price-to-FCF, the free cash flow per share of the past 10 years are inflation-adjusted and averaged. The result is used for P/FCF calculation. Since it looks at the average over the last 10 years, the Cyclically Adjusted Price-to-FCF is also called CAPFCF Ratio.

The Shiller PE Ratio was first used by professor Robert Shiller. He uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings per share of a company over the past 10 years. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted Price-to-FCF. The Cyclically Adjusted FCF per Share is the average of the inflation adjusted free cash flow per share of a company over the past 10 years.

NeoPharm Co's Cyclically Adjusted Price-to-FCF of today is calculated as

Cyclically Adjusted Price-to-FCF=Share Price/Cyclically Adjusted FCF per Share
=14270.00/983.66
=14.51

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

During the past 13 years, the highest Cyclically Adjusted Price-to-FCF of NeoPharm Co was 122.45. The lowest was 9.90. And the median was 27.35.


Be Aware

Cyclically Adjusted Price-to-FCF works better for cyclical companies. It gives you a better idea on the company's real free cash flow value.


NeoPharm Co Cyclically Adjusted FCF per Share Related Terms

Thank you for viewing the detailed overview of NeoPharm Co's Cyclically Adjusted FCF per Share provided by GuruFocus.com. Please click on the following links to see related term pages.


NeoPharm Co Business Description

Traded in Other Exchanges
N/A
Address
928 Tamnip-dong, Yuseong-gu, Daejon, KOR, 305-510
NeoPharm Co Ltd is a South Korean company operating in the household and personal products. The products of the company include skin care brand, skin barrier special dermo cosmetic brand, hospital functional products, and life moisturizing body professional brand.

NeoPharm Co Headlines

No Headlines